Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
03/2009
03/05/2009WO2009028625A1 Method of binding protein to support using tamavidin
03/05/2009WO2009028582A1 Transformants capable of producing isopropanol
03/05/2009WO2009028581A1 Cancer-related genes, cdca5, epha7, stk31 and wdhd1
03/05/2009WO2009028580A1 Ebi3, dlx5, nptx1 and cdkn3 for target genes of lung cancer therapy and diagnosis
03/05/2009WO2009028575A1 Activator for blood coagulation factor vii promoter and utilization of the same
03/05/2009WO2009028531A1 Docrine polypeptide and method of purifying recombinant fused protein using the same
03/05/2009WO2009028521A1 Pkib and naaladl2 for target genes of prostate cancer therapy and diagnosis
03/05/2009WO2009028421A1 Transfection device utilizing sericin
03/05/2009WO2009028418A1 Cyclosporin a-binding protein
03/05/2009WO2009028345A1 Dimer amidite for synthesis of nucleic acid, nucleic acid synthesis method
03/05/2009WO2009028338A1 Novel oxidase gene and method of producing 3-indole-pyruvic acid using the gene
03/05/2009WO2009028319A1 Peptide derived from ephb6 mutant capable of binding to hla-a24 or hla-a2 molecule
03/05/2009WO2009028294A1 Mutant lipase and use thereof
03/05/2009WO2009028253A1 Peptide production method
03/05/2009WO2009028218A1 Detection of bacteria belonging to the genus campylobacter targeting cell expansion lethal toxin
03/05/2009WO2009027978A1 NUCLEIC ACID SEQUENCES COMPRISING NF-ϰB BINDING SITE WITHIN O(6)-METHYLGUANINE-DNA-METHYLTRANSFERASE (MGMT) PROMOTER REGION AND USES THEREOF FOR THE TREATMENT OF CANCER AND IMMUNE-RELATED DISORDERS
03/05/2009WO2009027830A2 Bacterially-derived, intact minicells that encompass plasmid-free functional nucleic acid for in vivo delivery to mammalian cells
03/05/2009WO2009027572A1 Use of active recombinant chymosin
03/05/2009WO2009027539A2 Method for producing a transgenic plant cell, a plant or a part thereof with increased resistance to plant disease
03/05/2009WO2009027527A2 Rna antagonist compounds for the modulation of fabp4/ap2
03/05/2009WO2009027507A2 Aptamers which bind to a target molecule involved in haemostasis
03/05/2009WO2009027495A1 Method for manufacturing a modified peptide
03/05/2009WO2009027471A1 Methods for increasing protein titers
03/05/2009WO2009027412A1 A recombinant koi herpesvirus (khv) or cyprinid herpesvirus 3 (cyhv-3) and a vaccine for the prevention of a disease caused by khv/cyhv-3 in cyprinus carpio carpio or cyprinus carpio koi
03/05/2009WO2009027351A1 Plasmid production and expression of recombinant proteins in cells cultivated without antibiotics
03/05/2009WO2009027335A2 Polypeptides, such as lipases, capable of altering the seed storage content in transgenic plants
03/05/2009WO2009027313A2 Pathogen control genes and methods of use in plants
03/05/2009WO2009026892A1 Oligonucleotides for the inhibition of mouse major satellite sequences
03/05/2009WO2009026723A1 Antigenic compositions and use of same in the targeted delivery of nucleic acids
03/05/2009WO2009026660A1 Dendritic cell marker and uses thereof
03/05/2009WO2009026653A1 Neuroplasticity assay
03/05/2009WO2009012384A3 Compositions, kits, and methods for the diagnosis, prognosis, and monitoring of immune disorders using galectin-1
03/05/2009WO2009012382A3 Compositions, kits, and methods for the modulation of immune responses using galectin-1
03/05/2009WO2009009589A3 System and methods for normalizing data in nucleic acid amplification procedures
03/05/2009WO2009006584A3 Methods and compositions for identifying cellular rna transcripts
03/05/2009WO2009006300A3 Production cell lines for adenoviral manufacturing
03/05/2009WO2009005564A3 Cellulose- and hemicellulose-degradation enzyme -encoding nucleotide sequences with refined translational kinetics and methods of making same
03/05/2009WO2009004575A3 Cartilage-specific expression
03/05/2009WO2009003676A8 Method for the generation of a non-human animal with an oncogene
03/05/2009WO2009003178A3 Reagents and methods for cyanobacterial production of bioplastics and biomaterials
03/05/2009WO2009001135A3 Combinatorial libraries and related methods
03/05/2009WO2008156661A3 BACTERIAL MEDIATED TNF-α GENE SILENCING
03/05/2009WO2008155120A3 Methods and compositions for treating mucositis
03/05/2009WO2008153903A3 Heterologous and homologous cellulase expression system
03/05/2009WO2008153676A3 Pentose phosphate pathway and fermentation enzyme-encoding nucleotide sequences with refined translational kinetics and methods of making same
03/05/2009WO2008152523A9 Meganuclease variants cleaving a dna target sequence from the mouse rosa26 locus and uses thereof
03/05/2009WO2008150892A3 Compositions for production of soybean with elevated oil content
03/05/2009WO2008148845A3 Method of preparing a dough-based product
03/05/2009WO2008148831A3 Antigen presenting cells
03/05/2009WO2008142034A3 Plants with increased tolerance and/or resistance to environmental stress and increased biomass production
03/05/2009WO2008141308A3 Gene expression and pain
03/05/2009WO2008137881A3 Ehrlichia ewingii proteins, nucleic acids, and methods of their use
03/05/2009WO2008130372A3 Production of sterols in oleaginous yeast and fungi
03/05/2009WO2008126083A3 Methods for identification and selection of human embryonic stem cell derived cells
03/05/2009WO2008125222A3 New modulation molecules for an improved regulated expression system
03/05/2009WO2008118957A3 Methods for modulating embryonic stem cell differentiation
03/05/2009WO2008109531A4 Nucleic acid compounds for inhibiting hsd11b1 expression and uses thereof
03/05/2009WO2008109520A3 Nucleic acid compounds for inhibiting cxc gene expression and uses thereof
03/05/2009WO2008109375A3 Nucleic acid compounds for inhibiting pik3c gene expression and uses thereof
03/05/2009WO2008104974A3 Composition and methods for modulating cell proliferation and cell death
03/05/2009WO2008095192A8 Gene silencing by single-stranded polynucleotides
03/05/2009WO2008087562A3 Methods and compositions for modulating the mirna pathway
03/05/2009WO2008066752A3 Targeted therapeutics based on engineered proteins for tyrosine kinases receptors, including igf-ir
03/05/2009WO2008054713A3 Tissue specific gene therapy treatment
03/05/2009WO2005094355A3 Methods for altering protein production rates
03/05/2009US20090064376 Use of untranslated region of osmotin gene to enhance transgene expression in plants
03/05/2009US20090064375 Paraquat Resistance Gene and a Vascular Tissue- and Trichome-specific Promoter
03/05/2009US20090064374 Expression cassettes for seed-preferential expression in plants
03/05/2009US20090064373 Plants with altered root architecture, related constructs and methods involving genes encoding nucleoside diphosphatase kinase (ndk) polypeptides and homologs thereof
03/05/2009US20090064372 Transformed Plant Expressing a Dextransucrase and Synthesizing a Modified Starch
03/05/2009US20090064371 Methods for Increasing the Resistance of Plants to Hypoxic Conditions
03/05/2009US20090064370 Habanero pepper hybrid px11423487
03/05/2009US20090064369 Habanero pepper hybrid px11423486
03/05/2009US20090064368 Watermelon line was146-4197
03/05/2009US20090064367 Tomato line chd 15-2062
03/05/2009US20090064366 Squash line zgn 130-1041t
03/05/2009US20090064365 Squash line ycn 130-1053t
03/05/2009US20090064364 Squash line ypc 130-1035t
03/05/2009US20090064363 Pumpkin line hwn 130-1039t
03/05/2009US20090064362 Pumpkin line hwn 130-1018t
03/05/2009US20090064353 Transgenic or recombinant non-human mammals and their uses in screening psychoactive medicines
03/05/2009US20090064352 Creating poultry and other animals resistant to viral disease
03/05/2009US20090064351 Transgenic bird producing erythropoietin and method of constructing the same
03/05/2009US20090062543 Uv excitable fluorescent energy transfer dyes
03/05/2009US20090062229 Method and composition for reducing the expression of rock-ii
03/05/2009US20090062228 piRNA and uses related thereto
03/05/2009US20090062226 Method and Compositions for Inhibiting MAGE Protein Interaction With KAP-1
03/05/2009US20090062225 Double-stranded ribonucleic acid (dsRNA), and its use in mediating RNA interference to inhibit the expression of one of the genes of the JC virus and the use of the dsRNA to treat pathological processes mediated by JC virus infection, such as PML; sense, antisense
03/05/2009US20090062207 Methods and compositions for the treatment of gastrointestinal disorders
03/05/2009US20090062199 Nogo Receptor Polypeptides and Polypeptide Fragments and Uses Thereof
03/05/2009US20090062190 Transcriptional Regulation of Cytokines by LITAF and STAT (6)(B)
03/05/2009US20090062189 Tumor suppressor protein and nucleotide encoding same
03/05/2009US20090062188 Disease-Associated Protein
03/05/2009US20090062186 Compounds Binding To P-Selectin
03/05/2009US20090062148 Substrate preparation process
03/05/2009US20090062147 Methods for synthesis of encoded libraries
03/05/2009US20090062143 Translation initiation region sequences for optimal expression of heterologous proteins
03/05/2009US20090062142 Methods for enhancing bacterial cell display of proteins and peptides
03/05/2009US20090062139 Phytases, nucleic acids encoding them and methods for making and using them
03/05/2009US20090062137 Methods For Identification, and Compounds Useful For The Treatment Of Degenerative & Inflammatory Diseases